Invivyd (IVVD) Depreciation & Amortization (CF) (2021 - 2025)
Invivyd (IVVD) posted Depreciation & Amortization (CF) of $149000.0 for Q4 2025, little changed on a QoQ basis from $149000.0 in Q3 2025, and down 86.25% year-over-year from $1.1 million in Q4 2024.
Invivyd (IVVD) Depreciation & Amortization (CF) (2021 - 2025) Analysis & Trends
Invivyd's Depreciation & Amortization (CF) history runs 5 years deep, the most recent figure standing at $149000.0 for Q4 2025.
- Quarterly Depreciation & Amortization (CF) fell 86.25% year-over-year to $149000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $755000.0 (down 48.5% YoY) and the FY2025 annual result came in at $755000.0, down 48.5% from the prior year.
- Depreciation & Amortization (CF) was $149000.0 for Q4 2025 at Invivyd, roughly flat from $149000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1.1 million in Q4 2024 and bottomed at $1000.0 in Q4 2021.
- A 5-year average of $161352.9 and a median of $121000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) soared 2900.0% — and 2025, when it plunged 86.25%.
- Invivyd's Depreciation & Amortization (CF) stood at $1000.0 in 2021, then jumped by 2600.0% to $27000.0 in 2022, then jumped by 344.44% to $120000.0 in 2023, then jumped by 803.33% to $1.1 million in 2024, then plunged by 86.25% to $149000.0 in 2025.
- Business Quant data shows IVVD's Depreciation & Amortization (CF) at $149000.0 in Q4 2025, $149000.0 in Q3 2025, and $151000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 41.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.20 Mn |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn | 149,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 149,000.00 |
| Dec 31, 2025 | 149,000.00 |
| Sep 30, 2025 | 149,000.00 |
| Sep 30, 2025 | 149,000.00 |
| Jun 30, 2025 | 151,000.00 |
| Jun 30, 2025 | 151,000.00 |
| Mar 31, 2025 | 306,000.00 |
| Mar 31, 2025 | 306,000.00 |
| Dec 31, 2024 | 1.08 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 132,000.00 |
| Sep 30, 2024 | 132,000.00 |
| Jun 30, 2024 | 128,000.00 |
| Jun 30, 2024 | 128,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Dec 31, 2023 | 120,000.00 |
| Dec 31, 2023 | 120,000.00 |
| Sep 30, 2023 | 119,000.00 |
| Sep 30, 2023 | 119,000.00 |